---
title: "Global Longlife Hospital and Research Ltd (543520) — Share Price, Financials & Analysis"
symbol: "543520"
company: "Global Longlife Hospital and Research Ltd"
canonical: "https://tapetide.com/stocks/543520"
isin: "INE0J2K01014"
nse_symbol: "GLOBALLONGLIFEHOSPITALRESEARCHLTD"
bse_code: "543520"
sector: "Healthcare Services"
industry: "Hospitals"
market_cap_cr: 14.77
generated_at: "2026-09-13T19:09:00.974Z"
---

# Global Longlife Hospital and Research Ltd (543520)

Canonical page: https://tapetide.com/stocks/543520

## Company

- **NSE Symbol:** GLOBALLONGLIFEHOSPITALRESEARCHLTD
- **BSE Code:** 543520
- **ISIN:** INE0J2K01014
- **Sector:** Healthcare Services
- **Industry:** Hospitals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2022-05-04
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** globalhospital.co.in

## About

Incorporated in 2015, Global Longlife Hospital & Research Ltd is in the business of Health Care and Hospitals[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:41:05.685777Z.

- **Market Cap:** ₹14.77 Cr
- **Classification:** SME
- **P/E (reported):** -8.6
- **EPS (reported):** ₹0
- **Book Value:** ₹22.62
- **Price to Book:** 0.62
- **Dividend Yield:** 0%
- **ROE:** -7.24%
- **ROCE:** -4.16%
- **Debt to Equity:** 0
- **Revenue (yearly):** ₹0 Cr
- **Net Income:** ₹-1.7 Cr
- **EBITDA:** ₹-1 Cr
- **52-Week High:** ₹26.73
- **52-Week Low:** ₹9
- **RSI (14):** 72.86

## Tapetide Score

- **Score:** 45 / 100
- **Score date:** 2026-09-04
- **Archetype:** Cheap but Weak
- **What it means:** A low multiple sitting on weak financials. Worth establishing what the market is discounting before treating the low valuation as an opportunity — weak fundamentals often justify it.
- **Pillar profile:** Quality: Weak · Valuation: Cheap · Momentum: Falling
- **Percentile:** 28.3 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 73.18 | 9% |
| growth | 1.1 | 9% |
| momentum | 17.71 | 12% |
| ownership | 50 | 24% |
| quality | 40.69 | 22% |
| valuation | 67.34 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Stock is trading at 0.64 times its book value

### Weaknesses

- Company has low interest coverage ratio.
- Promoter holding is low: 22.9%
- Company has a low return on equity of -8.85% over last 3 years.
- Promoter holding has decreased over last 3 years: -31.4%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -136.61% | 11.05% | -147.88% |
| ebitda margin growth | 33.33% | — | — | — |
| net income growth | 37.5% | -950% | -22.73% | -147.22% |
| revenue growth | 0% | -100% | -100% | -100% |
| roce | — | -397.14% | -18.27% | 6.38% |
| roe | — | — | -4.98% | -134.36% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 19.94 | 12.87 | 11.8 | 11.7 | 12.33 | 1.18 | 0.58 | 0 | 0 | 0 |
| Expenses | 13.18 | 11.61 | 10.03 | 9.44 | 9.62 | 4.2 | 4.39 | 0.35 | 0.6 | 0.4 |
| Operating Profit | 6.76 | 1.26 | 1.77 | 2.26 | 2.71 | -3.02 | -3.81 | -0.35 | -0.6 | -0.4 |
| OPM % | 33.9 | 9.79 | 15 | 19.32 | 21.98 | -255.93 | -656.9 | — | — | — |
| Other Income | 0.07 | 0.16 | 0.07 | 0.17 | 0.02 | 0.04 | 5.69 | -0.67 | 0.01 | 0 |
| Interest | 0.09 | 1.31 | 0.2 | 0.2 | 0.41 | 0.36 | 0.28 | 0 | 0 | 0 |
| Depreciation | 0.58 | 0.57 | 0.58 | 0.59 | 0.61 | 0.64 | 0.48 | 0 | 0 | 0 |
| Profit before tax | 6.16 | -0.46 | 1.06 | 1.64 | 1.71 | -3.98 | 1.12 | -1.02 | -0.59 | -0.4 |
| Tax % | 0 | -78.26 | 29.25 | 35.37 | 39.77 | -19.1 | -11.61 | 2.94 | 123.73 | 0 |
| Net Profit | 6.17 | -0.1 | 0.76 | 1.07 | 1.03 | -3.22 | 1.24 | -1.04 | -1.32 | -0.4 |
| EPS in Rs | 8.81 | -0.14 | 0.72 | 1.02 | 0.98 | -3.07 | 1.18 | -0.99 | -1.26 | -0.38 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 33.44 | 33.32 | 32.7 | 32.44 | 23.38 | 13.46 | 0.31 | 0 |
| Expenses | 26.61 | 29.88 | 27.26 | 24.14 | 19.3 | 13.68 | 4.45 | 1 |
| Operating Profit | 6.83 | 3.44 | 5.44 | 8.3 | 4.08 | -0.22 | -4.14 | -1 |
| OPM % | 20.42 | 10.32 | 16.64 | 25.59 | 17.45 | -1.63 | -1335.48 | — |
| Other Income | 0.08 | 0.03 | 0.06 | 0.17 | 0.24 | 0 | 5.02 | 0.01 |
| Interest | 2.07 | 2.41 | 2.44 | 1.62 | 0.45 | 0.8 | 0.3 | 0 |
| Depreciation | 2.15 | 2.13 | 1.31 | 1.14 | 1.17 | 1.25 | 0.48 | 0 |
| Profit before tax | 2.69 | -1.07 | 1.75 | 5.71 | 2.7 | -2.27 | 0.1 | -0.99 |
| Tax % | 49.07 | -18.69 | -16.57 | 37.3 | 32.59 | -3.52 | -100 | 73.74 |
| Net Profit | 1.36 | -0.86 | 2.05 | 3.57 | 1.83 | -2.19 | 0.2 | -1.72 |
| EPS in Rs | 1.94 | -1.23 | 2.93 | 5.1 | 1.74 | -2.09 | 0.19 | -1.64 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 7 | 7 | 7 | 7 | 10.5 | 10.5 | 10.5 | 10.5 |
| Reserves | 5.35 | 4.49 | 6.68 | 9.96 | 53.79 | 15.43 | 16.29 | 13.25 |
| Borrowings | 27.18 | 23.51 | 17.04 | 8.69 | 9.29 | 12.74 | 0 | 0 |
| Other Liabilities | 3.77 | 6.92 | 6.06 | 8.33 | 2.36 | 3.07 | 0.06 | 0.01 |
| Total Liabilities | 43.3 | 41.92 | 36.78 | 33.98 | 75.94 | 41.74 | 26.85 | 23.76 |
| Fixed Assets | 20.17 | 18.72 | 17.46 | 16.71 | 16.52 | 17.27 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 1.03 | 0 | 0 | 0 |
| Investments | 0.1 | 0.1 | 0.47 | 0.1 | 0.1 | 0.03 | 0.03 | 0 |
| Other Assets | 23.03 | 23.1 | 18.85 | 17.17 | 58.29 | 24.44 | 26.82 | 23.76 |
| Total Assets | 43.3 | 41.92 | 36.78 | 33.98 | 75.94 | 41.74 | 26.85 | 23.76 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 5.4 | 3.9 | 6.88 | 9.42 | -40.42 | -5.07 | 12.32 | -4.51 |
| Cash from Investing Activity | -0.33 | -0.04 | 0.02 | 0.01 | -1.9 | -0.82 | 21.8 | 0.04 |
| Cash from Financing Activity | -4.77 | -3.05 | -7.22 | -9.66 | 45.7 | 2.67 | -13.01 | 0 |
| Net Cash Flow | 0.31 | 0.81 | -0.33 | -0.22 | 3.38 | -3.22 | 21.11 | -4.47 |
| Free Cash Flow | 5 | 3.79 | 6.84 | 8.96 | -42.42 | -6.1 | 33.42 | -4.51 |
| CFO/OP | 79 | 113 | 126 | 105 | -960 | 2259 | -304 | 401 |

### Ratios

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 94.85 | 68.68 | 87.51 | 100.25 | 151.43 | 52.88 | 376.77 | — |
| Inventory Days | 169.49 | 157.97 | 34.46 | 88.98 | 69.12 | 131.64 | 0 | — |
| Days Payable | 229.91 | 391.69 | 138.68 | 432.74 | 110.43 | 765.9 | — | — |
| Cash Conversion Cycle | 34.44 | -165.03 | -16.71 | -243.52 | 110.13 | -581.38 | 376.77 | — |
| Working Capital Days | 19.21 | 12.16 | 7.14 | -29.7 | 344.86 | -238.36 | 1283.39 | — |
| ROCE % | — | 3.81 | 12.75 | 26.22 | 6.35 | -2.51 | -13.69 | -3.92 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 54.29% | 54.29% | 54.29% | 54.29% | 54.29% | 54.29% | 54.29% | 54.9% | 55.1% | 35.44% | 22.88% | 22.88% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 35.51% | 36.27% | 37.13% | 34.62% | 31.9% | 31.79% | 33.71% | 33.2% | 33.31% | 53.48% | 57.21% | 56.32% |
| Others | 10.2% | 9.45% | 8.58% | 11.1% | 13.81% | 13.92% | 12% | 11.9% | 11.59% | 11.09% | 19.91% | 20.8% |
| No. of Shareholders | 880 | 935 | 947 | 1010 | 974 | 989 | 938 | 917 | 915 | 985 | 1149 | 1133 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 10 / 2 / 7

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 12.76 | Buy |
| EMA (10) | 13 | Buy |
| SMA (20) | 11.7 | Buy |
| EMA (20) | 12.36 | Buy |
| SMA (50) | 11.74 | Buy |
| EMA (50) | 12.03 | Buy |
| SMA (100) | 12.11 | Buy |
| EMA (100) | 12.74 | Buy |
| SMA (200) | 15.09 | Sell |
| EMA (200) | 15.49 | Sell |

### Oscillators — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 74.97 | Sell |
| MACD (12,26,9) | 0.61 | Buy |
| Stochastic (14,3,3) | 93.21 | Sell |
| ADX (14) | 19.17 | Neutral |
| Williams %R (14) | -6.58 | Sell |
| ATR (14) | 0.81 | High Volatility |
| ROC (12) | 36.78 | Buy |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 71.32 | Sell |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-25 | [Alteration In Objects Clause Of The Company.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8daad7ec-4139-428b-8490-b0e98f3bec05.pdf) |
| 2026-08-19 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4B642EC1_9CD1_40A8_A1BB_B46D43964762_105831.pdf) |
| 2026-08-13 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=C157B412_1566_4B6C_AA80_69830EA98ABA_102107.pdf) |
| 2026-08-10 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=EAE600E9_176A_48F5_9370_93F5A1810593_113434.pdf) |
| 2026-08-03 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5D4E7294_14CC_490A_88CD_6982EE06817A_123157.pdf) |
| 2026-07-24 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c4a96dd4-325a-40af-b95c-465e3a912447.pdf) |
| 2026-06-26 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa74c0f2-c3dc-44c5-bad4-799266147ed2.pdf) |
| 2026-06-26 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce103a12-0928-4705-a4e4-60a4054fd944.pdf) |
| 2026-06-26 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37fe50f5-d7ac-46d0-9cdf-939cf98bc734.pdf) |
| 2026-06-26 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c518234-bf1e-4613-bd6d-27a3d63eb8c1.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Feb - Members approved appointment of Mahesh Kumar Girdhar as Independent Director, passed Feb 8, 2026 via postal ballot. | [Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot 9 Feb - Members approved appointment of Mahesh Kumar Girdhar as Independent Director, passed Feb 8, 2026 via postal ballot.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/77b86cc5-f613-4aed-9c29-31dcbd9f0b72.pdf) |
| 9 Feb - Ashok Sharma appointed Independent Director effective Feb 10, 2026 for five-year term. | [Announcement under Regulation 30 (LODR)-Change in Directorate 9 Feb - Ashok Sharma appointed Independent Director effective Feb 10, 2026 for five-year term.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d66c8f04-0e2c-489f-8e73-390791ffec9b.pdf) |
| 9 Feb - Appointment of Mr. Mahesh Kumar Girdhar (DIN:10270848) as Independent Director passed Feb 8, 2026. | [Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 9 Feb - Appointment of Mr. Mahesh Kumar Girdhar (DIN:10270848) as Independent Director passed Feb 8, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dbc21e7d-8bbd-49a8-8423-190e3a9303b8.pdf) |
| 7 May - Board approved FY26 audited results, name change proposal, and shift main object from healthcare to trade/services. | [Audited Financial Results For The Half Year And Year Ended March 31, 2026 Along With Audit Report 7 May - Board approved FY26 audited results, name change proposal, and shift main object from healthcare to trade/services.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/5aa59a76-6d15-44ea-9357-2863cc83e086.pdf) |
| 7 May - Board approved FY26 audited results and proposed name and main-object changes on May 7, 2026. | [Board Meeting Outcome for Consideration Of Audited Financial Results For The Half Year And Year Ended March 31, 2026 And Other Matters 7 May - Board approved FY26 audited results and proposed name and main-object changes on May 7, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/762069cc-c5df-4b15-8d7d-16c7d6eb8eed.pdf) |
| 7 Jan - RTA certifies no dematerialization requests up to Dec 31, 2025 under Regulation 74(5). | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Jan - RTA certifies no dematerialization requests up to Dec 31, 2025 under Regulation 74(5).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/21d37809-5e8a-4a27-b23f-574cdf3400f0.pdf) |
| 4 Feb - Details of the scheduled meetings with Analysts / Institutional Investors. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 4 Feb - Details of the scheduled meetings with Analysts / Institutional Investors.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ce6a3be5-4ba9-4671-95ca-5f083c71f251.pdf) |
| 31 Mar - Mr. Hiren Mandaliya appointed Independent Director effective March 31, 2026 for five years, subject to shareholders' approval. | [Announcement under Regulation 30 (LODR)-Change in Management 31 Mar - Mr. Hiren Mandaliya appointed Independent Director effective March 31, 2026 for five years, subject to shareholders' approval.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/85af4117-6687-45cf-a985-d27e4148c470.pdf) |
| 31 Mar - Board appointed Hiren Mandaliya as Additional Independent Director for five years effective March 31, 2026, subject to shareholder approval. | [Board Meeting Outcome for Outcome Of Meeting Of Board Held Today I.E. Tuesday, March 31, 2026 31 Mar - Board appointed Hiren Mandaliya as Additional Independent Director for five years effective March 31, 2026, subject to shareholder approval.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fdb8ae26-80bc-40e3-915e-5fed7d1f7417.pdf) |
| 30 Apr - Board meets May 7, 2026 to approve audited results, consider name change and object clause alteration. | [Board Meeting Intimation for Consideration Of Audited Financial Results For The Half Year And Year Ended On March 31, 2026. 30 Apr - Board meets May 7, 2026 to approve audited results, consider name change and object clause alteration.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/384b00d0-cb79-403d-b230-14b6923d2fe7.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-05-07 | [Audited Financial Results For The Half Year And Year Ended March 31 2026 Along With Audit Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5aa59a76-6d15-44ea-9357-2863cc83e086.pdf) |
| 2025-11-12 | [Unaudited Financial Results For The Half Year Ended September 30 2025 Along With Limited Review Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd27c95e-2a22-42c7-beb1-c548969e331f.pdf) |
| 2025-04-28 | [Audited Financial Results For The Half Year And Year March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=626e0071-ad9c-42e8-8845-05d1e718c60f.pdf) |
| 2024-10-28 | [Financial Results For The Half Year Ended On September 30, 2024 Along With Limited Review Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d6f1344-08df-49a7-808c-bb4b3650af00.pdf) |
| 2024-05-20 | [Financial Results For The Half Year And Year Ended March 31, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a62d29a-89f5-465f-84ae-54a7ea55a437.pdf) |
| 2023-11-11 | [Unaudited Financial Results For The Half Year Ended On September 30, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c17cb0fa-5604-4b46-b747-ac829346e2e1.pdf) |
| 2023-05-30 | [Audited Financial Results For The Half Year And Year Ended On March 31, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b39d04c-c16f-4a9a-92c7-bf82585ef826.pdf) |
| 2022-11-12 | [Unaudited Financial Result For The Half Year Ended On September 30, 2022.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d8ce91e-dedd-475b-b0b5-a14033d650d2.pdf) |
| 2022-05-30 | [Board Meeting Outcome for Board Meeting Outcome For Audited Financial Result For The Half Year And Year Ended On March 31, 2022.<BR>](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d4d414d-5108-4030-b84c-6439f6b5779e.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2011 from nse](https://archives.nseindia.com/annual_reports/AR_RALLIS_2010_2011_17062011050505.zip) |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/85cd03d3-c76a-41d7-9bad-588785991fa2.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/af662f6d-33ff-44d0-b3f0-2c81ddf727b4.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/719bbb89-1ff3-4829-8f1d-38d062305997.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ca1d533c-151d-4e71-8893-83459ef8da9e.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/35cc0e3c-20a3-420c-b343-0bd899795c9d.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/03612563-318f-4e1b-9f64-bb784bfae70e.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/32d1d297-98ac-423f-9e43-bcb7a608251a.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/543520/75342543520.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/500355/73058500355.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2025 | [Concall - Oct 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/10274744-2ad8-4d63-b4fa-7339d904f92a.pdf) |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9d564054-f067-4f55-8eda-11d6ed55ad0b.pdf) |
| Oct 2022 | [Concall - Oct 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f64fcfff-655e-4a4e-9a95-7f52b2823883.pdf) |
| Oct 2021 | [Concall - Oct 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e3e46b38-2f3b-42c2-af0d-e08b25e23a31.pdf) |
| Oct 2020 | [Concall - Oct 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ae4e1b6b-4da6-485b-be04-d92bf7d6aa7b.pdf) |
| Oct 2019 | [Concall - Oct 2019](https://www.bseindia.com/xml-data/corpfiling/AttachHis/adef2fa1-631b-4305-8c8c-e69eb2a5d54c.pdf) |
| Oct 2018 | [Concall - Oct 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/10/7b67c54a-0d25-46b9-af9b-e6a219034b0f.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/351e14b0-cd0e-44c7-8e11-b613f3ef05df.pdf) |
| May 2023 | [Concall - May 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6739eff5-91e6-4002-918c-637e18cb322f.pdf) |
| May 2018 | [Concall - May 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/5/381fafe6-c6d4-42d0-bc67-2517a0c8d340.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:09:00.974Z.